Georgios Chamilos Selected Research

Therapeutics

1/2021	Are All Patients with Cancer at Heightened Risk for Severe Coronavirus Disease 2019 (COVID-19)?
10/2014	Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer.
8/2008	Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.
9/2006	Defining the diagnosis of invasive aspergillosis.
8/2006	The rationale of combination antifungal therapy in severely immunocompromised patients: empiricism versus evidence-based medicine.
9/2005	Aspergillus susceptibility testing in patients with cancer and invasive aspergillosis: difficulties in establishing correlation between in vitro susceptibility data and the outcome of initial amphotericin B therapy.
6/2005	Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin.
4/2005	Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Georgios Chamilos Research Topics

Disease

10	Infections 06/2023 - 11/2005
9	Neoplasms (Cancer) 05/2024 - 04/2005
9	Mycoses (Diseases, Fungus) 01/2020 - 08/2006
8	Aspergillosis 05/2024 - 09/2005
6	COVID-19 11/2023 - 01/2021
5	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 03/2011
4	Mucormycosis 01/2023 - 10/2008
4	Invasive Fungal Infections 01/2018 - 08/2006
4	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2015 - 08/2009
4	Zygomycosis (Phycomycosis) 05/2009 - 04/2005
3	Hematologic Neoplasms (Hematological Malignancy) 08/2008 - 09/2007
2	Pneumonia (Pneumonitis) 11/2023 - 10/2022
2	Febrile Neutropenia 10/2023 - 06/2005
2	Cross Infection (Nosocomial Infection) 06/2023 - 09/2022
2	Necrosis 01/2021 - 09/2007
2	Inflammation (Inflammations) 03/2014 - 05/2009
2	Chronic Granulomatous Disease 03/2014 - 08/2013
2	Starvation 05/2010 - 07/2008
2	Invasive Pulmonary Aspergillosis 04/2007 - 03/2007
2	Body Weight (Weight, Body) 04/2007 - 03/2007
1	Pulmonary Aspergillosis 04/2024
1	Hematologic Diseases (Blood Diseases) 01/2023
1	Virus Diseases (Viral Diseases) 01/2023
1	Critical Illness (Critically Ill) 10/2022
1	Sepsis (Septicemia) 08/2021
1	Shock 01/2021
1	Opportunistic Infections (Opportunistic Infection) 01/2018
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2017
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2014
1	Colitis 03/2014
1	Bites and Stings (Sting) 11/2012
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2011
1	Invasive Candidiasis 07/2009
1	Leukemia 09/2007
1	Cryptococcal Meningitis 08/2006

Drug/Important Bio-Agent (IBA)

4	Anti-Bacterial Agents (Antibiotics)IBA 06/2023 - 06/2005
4	Antimicrobial PeptidesIBA 03/2015 - 08/2009
4	DNA (Deoxyribonucleic Acid)IBA 11/2012 - 09/2006
4	Voriconazole (Vfend)FDA LinkGeneric 05/2009 - 04/2005
4	Antifungal AgentsIBA 08/2008 - 07/2005
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 03/2007
3	LipidsIBA 01/2020 - 04/2007
3	Melanins (Melanin)IBA 01/2020 - 01/2016
3	Phosphotransferases (Kinase)IBA 09/2019 - 11/2012
3	IronIBA 01/2018 - 09/2007
3	AutoantigensIBA 03/2015 - 03/2011
3	Amphotericin B (Amphotericin)FDA LinkGeneric 08/2008 - 09/2005
3	liposomal amphotericin B FDA Link 09/2007 - 03/2007
2	Agammaglobulinaemia Tyrosine KinaseIBA 05/2024 - 01/2018
2	Carbapenems (Carbapenem Antibiotics)IBA 06/2023 - 01/2023
2	AntibodiesIBA 01/2021 - 09/2006
2	ibrutinibIBA 09/2019 - 01/2018
2	Peptides (Polypeptides)IBA 03/2011 - 07/2008
1	Immunologic Factors (Immunomodulators)IBA 04/2024
1	Oxygen (Dioxygen)IBA 11/2023
1	insulin receptor-related receptor (IRR)IBA 06/2023
1	remdesivirIBA 01/2023
1	obinutuzumabIBA 01/2023
1	Rituximab (Mabthera)FDA Link 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	CytokinesIBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 08/2021
1	RicinIBA 01/2021
1	mucoricinIBA 01/2021
1	flotillinsIBA 01/2020
1	Pattern Recognition ReceptorsIBA 01/2017
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2017
1	InterleukinsIBA 09/2015
1	Muramidase (Lysozyme)IBA 01/2015
1	Adenosine Monophosphate (AMP)IBA 12/2014
1	NADP (NADPH)IBA 03/2014
1	InflammasomesIBA 03/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2014
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 03/2014
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 03/2014
1	Interleukin-1 (Interleukin 1)IBA 03/2014
1	NADPH Oxidases (NAD(P)H oxidase)IBA 08/2013
1	B-Form DNA (B-DNA)IBA 11/2012
1	Proteins (Proteins, Gene)FDA Link 11/2012
1	AutoantibodiesIBA 03/2011
1	4-Aminobenzoic Acid (4 Aminobenzoic Acid)IBA 05/2010
1	SiderophoresIBA 05/2010
1	Antimicrobial Cationic PeptidesIBA 08/2009
1	RNA (Ribonucleic Acid)IBA 08/2009
1	Transcription Factors (Transcription Factor)IBA 07/2009
1	rhizoxinIBA 10/2008
1	posaconazole FDA Link 08/2008
1	Chelating AgentsIBA 07/2008
1	Deferasirox FDA Link 07/2008
1	GliotoxinIBA 02/2008
1	Liposomes (Liposome)IBA 03/2007
1	deoxycholate drug combination amphotericin BIBA 03/2007
1	EchinocandinsIBA 08/2006

Therapy/Procedure

8	Therapeutics 01/2021 - 04/2005
2	Length of Stay 01/2023 - 09/2022
1	Drug Therapy (Chemotherapy) 10/2023
1	Immunotherapy 10/2023
1	Intravesical Administration 10/2014
1	Hematopoietic Stem Cell Transplantation 09/2007